Discovery, Synthesis, and Optimization of Peptide-Based Antibiotics

Area of Science:

• Medicinal Chemistry
• Natural Products Chemistry
• Antimicrobial Drug Discovery

Background:

• Multidrug-resistant bacteria pose a significant global health and economic threat, necessitating the development of novel antibiotics.
• Peptide natural products are attractive candidates due to their unique mechanisms of action, which can slow resistance development.
• These peptides offer benefits such as immune modulation and broad-spectrum activity against challenging bacterial biofilms.

Purpose of the Study:

• To highlight recent advances in the total synthesis and development of peptide-based natural product antibiotics.
• To detail medicinal chemistry approaches used to optimize the activity of these antibiotic candidates.
• To showcase strategies for developing new treatments against Gram-positive, mycobacterial, and Gram-negative bacterial infections.

Main Methods:

• Total synthesis of various peptide natural products, including daptomycin, glycocin F, teixobactin, callyaerin A, lassomycin, trichoderin A, battacin, and paenipeptin C.
• Application of medicinal chemistry techniques to optimize antibiotic activity and overcome resistance.
• Utilizing specific synthetic strategies like on-resin ozonolysis and exploring modifications such as non-native linkages and lipid tail optimization.

Main Results:

• Successful synthesis and optimization of daptomycin, glycocin F, and alamethicin for Gram-positive infections.
• Identification of potent leads against *Lactobacillus plantarum* and *Mycobacterium tuberculosis* through structural modifications.
• Development of potent lipopeptide analogues against *Escherichia coli* and *Pseudomonas aeruginosa* by optimizing lipid tails.

Conclusions:

• Peptide natural products represent a vital resource for developing new antibiotics against resistant bacterial strains.
• Medicinal chemistry plays a crucial role in enhancing the efficacy and spectrum of activity of these compounds.
• The synthetic strategies employed provide valuable insights for future drug discovery efforts targeting critical bacterial infections.